Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy

Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy

Purpose To determine whether fertility preservation with ovarian stimulation (OS) results in treatment delay in breast cancer (BC) patients receiving neoadjuvant therapy (NAT). Methods This is a retrospective study of women screened for the prospective neoadjuvant ISPY2 trial at the University of Ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast cancer research and treatment 2017-08, Vol.165 (1), p.151-159
Hauptverfasser: Chien, A. Jo, Chambers, Julia, Mcauley, Fiona, Kaplan, Tessa, Letourneau, Joseph, Hwang, Jimmy, Kim, Mi-Ok, Melisko, Michelle E., Rugo, Hope S., Esserman, Laura J., Rosen, Mitchell P.
Format: Artikel
Sprache:eng
Schlagworte:
Adjuvant chemotherapy
Biopsy
Breast cancer
Cancer research
Cancer therapies
Care and treatment
Comparative analysis
Embryo transfer
Epidemiology
Fertility
Health aspects
Medicine
Medicine & Public Health
Neoadjuvant therapy
Oncology
Patients
Polymerase chain reaction
Preservation
Women
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To determine whether fertility preservation with ovarian stimulation (OS) results in treatment delay in breast cancer (BC) patients receiving neoadjuvant therapy (NAT). Methods This is a retrospective study of women screened for the prospective neoadjuvant ISPY2 trial at the University of California San Francisco. All patients were
ISSN:0167-6806
1573-7217
DOI:10.1007/s10549-017-4288-3